Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


The Interventional Suite Of The Future

Executive Summary

The cardiac interventional suite has historically been a setting where high-tech, cutting-edge tools are welcomed. But with hospitals scrutinizing expenditures more closely than ever before, such tools must now prove themselves. Hospitals looking to build new interventional suites, or modernize old ones, are placing a premium on technologies that can improve safety, efficiency, and flexibility while streamlining workflow. A handful of companies are now offering products designed to meet these needs, and providers are starting to take notice.

You may also be interested in...

Washington Roundup

The latest medical device regulatory and reimbursement news from Elsevier Business Intelligence's "The Gray Sheet."

Wireless Apps and Cloud Computing: The Future of Health Care?

The fast-paced world of medicine is in the midst of a staggering shift in information technology practices. More than 10,000 mobile health applications are already available and about 72% of physicians are using a smartphone. The key areas of interest center around imaging, monitoring, and reference, all of which require highly detailed and interactive software solutions.

Hybrid ORs Offer New Approach to Cardiac Disease

In the near future, patients who are brought into the hospital in need of a coronary bypass procedure could be wheeled into a hybrid operating room that holds both the operating room and the cardiac catheterization lab. This combination will allow physicians to treat many high risk heart patients in a less invasive manner.

Related Companies

Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts